Cancer mechanisms

Molecular characterization of cancer mechanisms


. Synthetic lethality guiding selection of drug combinations in ovarian cancer.
PLoS One, (14), 1, e0210859,, 2019.

Project Project Project

. Synthetic lethal combinations of low-toxicity drugs for breast cancer identified in silico by genetic screens in yeast.
Oncotarget, (9), 91, 36379-91,, 2018.

Project Project

. Mass spectrometric-bioinformatic identification of a protein subset that characterizes the cellular activity of anticancer peptides.
Journal of Proteome Research, (13), 11, 5250–5261,, 2014.


. Recurrence-free survival in prostate cancer is related to increased stromal TRAIL expression.
Cancer, (117), 6, 1172–1182,, 2011.


. Natural Immunity Enhances the Activity of a DR5 Agonistic Antibody and Carboplatin in the Treatment of Ovarian Cancer.
Molecular Cancer Therapeutics, (9), 4, 1007–1018,, 2010.


. The role of c-FLIPL in ovarian cancer: Chaperoning tumor cells from immunosurveillance and increasing their invasive potential.
Gynecologic Oncology, (117), 3, 451–459,, 2010.